EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Fetal de novo heterozygous variant in the isocitrate dehydrogenase 1 gene associated with growth restriction, skeletal, cerebral and vascular anomalies

Clara Illi iD, Josefine Koenigbauer iD, Wolfgang Henrich, Laura Fangmann, Charlotte Reinhardt, Sophia Ossmann, Alexander Weichert

Prenatal Diagnosis · 2023

DOI: 10.1002/pd.6433 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Clara Illi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics of Charité University Hospital, Berlin, Germany. Hauptthemen laut MEDLINE: Isocitrate Dehydrogenase, Fetal Growth Retardation, Abnormalities, Multiple. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Germline pathogenic variants in isocitrate dehydrogenase 1 (IDH1) can lead to a rare neurodevelopmental disorder called metaphyseal chondromatosis with D‐2‐hydroxyglutaric aciduria, including severe skeletal and cerebral anomalies. To the best of our knowledge, no prenatal case of an IDH1 pathogenic variant has been reported in literature. Somatic sequence variants in IDH1/2 genes are described in distinct cancers, premalignant diseases and rare inherited metabolic disorders. Amniocentesis and further genetic testing including trio exome sequencing were performed due to suspicious findings on a second trimester routine prenatal ultrasound examination. The fetus was found to have growth restriction, cerebral abnormalities (ex vacuo hydrocephalus, cerebellar and vermian hypoplasia, corpus callosum dysgenesis), brachycephaly, narrow chest, persistent left superior vena cava, liver calcifications, hyperechogenic bowel, short tubular bones and joint contractures. A de novo heterozygous variant in the IDH1 gene was detected via trio exome sequencing. The prenatal diagnosis of a de novo pathogenic variant in IDH1 in a fetus with the described phenotype, obtained through trio exome sequencing, helped parents and providers with an informed decision making about pregnancy management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Isocitrate DehydrogenaseFetal Growth RetardationAbnormalities, MultipleHumansFemalePregnancyHeterozygoteAdultUltrasonography, PrenatalExome Sequencing

Substanzen

Isocitrate DehydrogenaseIDH1 protein, human

Autor:innen und Institutionen

  • Department of Obstetrics of Charité University Hospital, Berlin, Germany.
  • Prenatal Diagnosis Bergmannstrasse, Berlin, Germany.

ORCID-Profile: Clara Illi, Josefine Koenigbauer

Zitieren

APA

Illi, C., Koenigbauer, J., Henrich, W., Fangmann, L., Reinhardt, C., Ossmann, S., & Weichert, A. (2023). Fetal de novo heterozygous variant in the isocitrate dehydrogenase 1 gene associated with growth restriction, skeletal, cerebral and vascular anomalies. Prenatal Diagnosis. https://doi.org/10.1002/pd.6433

Vancouver

Illi C, Koenigbauer J, Henrich W, Fangmann L, Reinhardt C, Ossmann S, et al. Fetal de novo heterozygous variant in the isocitrate dehydrogenase 1 gene associated with growth restriction, skeletal, cerebral and vascular anomalies. Prenatal Diagnosis. 2023. doi:10.1002/pd.6433

BibTeX
@article{Illi2023,
  author = {Illi, Clara and Koenigbauer, Josefine and Henrich, Wolfgang and Fangmann, Laura and Reinhardt, Charlotte and Ossmann, Sophia and Weichert, Alexander},
  title = {Fetal de novo heterozygous variant in the isocitrate dehydrogenase 1 gene associated with growth restriction, skeletal, cerebral and vascular anomalies},
  journal = {Prenatal Diagnosis},
  year = {2023},
  doi = {10.1002/pd.6433}
}
Kostenlos starten →